An older patient exhibits a shuffling gait, lack of facial expression, and tremors at rest. The nurse will expect the provider to order which medication for this patient?

A. A respiratory rate of 14

A respiratory rate of 14 is within the normal range and is not typically a reason to hold benztropine. Respiratory depression is not a common side effect of this medication.

B. A pulse of 102

A pulse rate of 102 is also within the normal range, and changes in heart rate are generally not a prominent side effect of benztropine. This finding alone is not a typical reason to hold the medication.

C. Blood pressure of 88/60 mmHg

This is the correct choice. Anticholinergic medications, like benztropine, can cause side effects such as a decrease in blood pressure. A blood pressure of 88/60 mmHg may be a concern, and the nurse should hold the dose and notify the physician.

D. A temperature of 100.2°F

An elevated temperature of 100.2°F is not a direct contraindication to benztropine administration. Fever is not a typical side effect of this medication, so an increased temperature alone is not a reason to hold the dose.

A. Carbidopa-levodopa

The symptoms described, including a shuffling gait, lack of facial expression, and tremors at rest, are characteristic of Parkinson's disease. Carbidopa-levodopa is a common medication used in the management of Parkinson's disease.

B. Donepezil

Donepezil is used in the treatment of Alzheimer's disease, a condition characterized by cognitive decline and memory impairment. It is not indicated for Parkinson's disease.

C. Rivastigmine

Rivastigmine is another medication used in the treatment of Alzheimer's disease, and it is also used in Parkinson's disease dementia. However, it is not the primary medication for the motor symptoms of Parkinson's disease.

D. Tacrine

Tacrine was once used in the treatment of Alzheimer's disease, but it is no longer commonly prescribed due to safety concerns and the availability of newer, safer medications. It is not indicated for Parkinson's disease.